SS&C Technologies to Acquire Calastone
Headquartered in London, Calastone operates the largest global funds network, connecting more than 4,500 of the world's leading financial organizations across 57 markets. The acquisition is expected to close in Q4 2025, subject to regulatory approvals. SS&C expects the acquisition to be accretive within 12 months and plans to fund the purchase with a combination of debt and cash on hand. Calastone's more than 250 staffers in London, Luxembourg, Hong Kong, Taipei, Singapore, New York and Sydney are expected to join SS&C Global Investor & Distribution Solutions, reporting to General Manager Nick Wright.
'We're excited to welcome Julien, the Calastone team and their valued clients to SS&C,' said Bill Stone, Chairman and CEO of SS&C Technologies. 'Together, we will create a more connected, automated, and intelligent global fund ecosystem — reducing complexity, enhancing client experience, and shaping the future of distribution and investment operations.'
The acquisition of Calastone reinforces SS&C's commitment to transforming investment operations and bolsters SS&C's ongoing geographic expansion. Calastone's global network and technology solutions complement SS&C's leadership in fund administration, transfer agency services, AI and intelligent automation. By combining capabilities, the two companies will deliver a unified, real-time operating platform to reduce cost, complexity, and operational risk across the global fund ecosystem as well as shaping distribution. This strategic alignment enables enhanced distribution, investor servicing, and operational scalability — empowering asset and wealth managers to innovate, diversify products, and deliver better outcomes for investors worldwide.
'We are pleased to be combining forces with SS&C in our joint mission to build the most comprehensive, intelligent and connected wealth and asset management ecosystem,' said Julien Hammerson, CEO of Calastone. 'SS&C's global scale and deep expertise across fund services and technology will enable us to accelerate innovation and deliver new digital capabilities to the market. We look forward to working together to deliver transformational services to asset and wealth managers and drive growth.'
Fernando Chueca, Managing Director on the Carlyle Europe Technology Partners investment advisory team, said: 'We are pleased to have supported Calastone through such a transformational period of growth for the business. Its well-established technology network represents a differentiated, automated offering and we believe the business is well-positioned to build upon its market position and business momentum. We are confident that SS&C is the right partner to continue Calastone's success, and we look forward to watching the company thrive in its next phase.'
SS&C was advised by Davis Polk & Wardwell LLP. Barclays served as exclusive financial advisor to Calastone and Linklaters and Mishcon De Reya served as legal advisors to Calastone in connection with the transaction.
About Calastone
Calastone is the largest global funds network, connecting the world's leading financial organisations.
Calastone's mission is to reduce complexity, risk and costs, enabling the industry to deliver greater value to investors. 4,500 clients in 57 countries and territories benefit from Calastone's services, processing over £250 billion of investment value each month.
Calastone is headquartered in London and has offices in Luxembourg, Hong Kong, Taipei, Singapore, New York and Sydney.
About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. More than 22,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $453 billion of assets under management as of March 31, 2025, Carlyle's purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,300 people in 29 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.
Additional information about SS&C (Nasdaq:SSNC) is available at www.ssctech.com.
Follow SS&C on X, LinkedIn and Facebook.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
FIBRA Macquarie (DBMBF) Q2 2025 Earnings Call Highlights: Record Performance Amid Macroeconomic ...
Consolidated Revenues: Record per certificate results in underlying US dollar terms. NOI (Net Operating Income): Record results driven by robust lease GLA performance. AFFO (Adjusted Funds From Operations): $30 million, an 8.6% increase year over year. Distribution Yield: Attractive dollarized cash yield of 8% with a mid 80% payout ratio. Leasing Activity: 1.3 million square feet executed, rental rates grew by 6.8% to $6.45 per square meter. Renewal Spreads: Achieved 28% on commercially negotiated leases. Industrial Occupancy: 94.8%, up 10 basis points sequentially. Retail Portfolio NOI Growth: 4.5% for the quarter. Retail Occupancy: 93.4%, up more than 130 basis points year over year. Real Estate Net LTV: Below 33% as of June 30. Liquidity: $420 million US. Debt Repayment: $50 million US during 2Q '25. FY25 AFFO Guidance: $115 to $119 million US. Cash Distributions Guidance: MXN2.45 per certificate for FY25. FX Assumption Update: Revised to MXN18.5 per US dollar from 20.5%. Warning! GuruFocus has detected 8 Warning Signs with DBMBF. Release Date: July 25, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points FIBRA Macquarie (DBMBF) reported record per certificate results in key metrics such as consolidated revenues, NOI, AFFO, and NAV for the second quarter of 2025. The industrial portfolio maintained a high occupancy rate of 94.8% and achieved a 6.8% increase in rental rates, reaching $6.45 per square meter. The company successfully executed 1.3 million square feet of leasing activity with notable renewal spreads of 28% on commercially negotiated leases. FIBRA Macquarie's retail portfolio showed steady improvements with a 4.5% NOI growth and occupancy reaching a post-pandemic high of 93.4%. The company maintains a strong balance sheet with a real estate net LTV below 33% and robust liquidity of $420 million US, allowing for strategic growth and development opportunities. Negative Points Macroeconomic uncertainties, including tariff negotiations and geopolitical factors, are contributing to slower decision-making and impacting new leasing activities. The company faces challenges in larger Class A buildings due to tenants' hesitance in making significant CapEx decisions amid the current macro backdrop. There is a general softness in near-shoring markets such as Monterrey, Juarez, and Reynosa, which remain relatively weak. FIBRA Macquarie's development program faces potential risks related to increased land prices and infrastructure costs, which could impact yield on cost levels. The company is trading at a significant discount to its asset value, raising questions about potential buybacks and capital allocation priorities. Q & A Highlights Q: What is the current gap between your interest rents and the market trends for your industrial portfolio? A: Simon Hanna, CEO, stated that they achieved record spreads of 28% in the second quarter. They are on track to meet their goal of double-digit spreads for the year, with only 5% of scheduled expirations remaining. They expect to maintain solid double-digit spreads with the remaining leases. Q: Can you provide insights into the retail activity and its resilience to tariff noise affecting the industrial portfolio? A: Simon Hanna, CEO, mentioned that retail, which contributes about 15% of their overall NOI, had a strong quarter. They see more tailwinds than headwinds for the second half of the year, with expectations of resilient performance in key metrics like occupancy and rental rates. The recent peso appreciation has also been beneficial. Q: Could you comment on the commercialization for the FRISA JV in Tijuana? A: Simon Hanna, CEO, expressed excitement about the project, which is still in preparatory stages. The location is favorable for both manufacturing and logistics due to its proximity to labor and transport connections. Tijuana shows relative activity compared to other near-shoring markets, and they feel confident about going vertical there earlier. Q: Are there any risks to the yield on cost levels between 9% and 11% for your CapEx program? A: Andrew McDonald-Hughes, CFO, stated they remain confident in maintaining those levels despite increases in land prices and infrastructure costs. They expect the lower end of the range in active markets like Tijuana and Mexico City, with other markets trending towards the midpoint. Q: Are there any refinancing activities planned to extend maturities or optimize your debt structure? A: Andrew McDonald-Hughes, CFO, confirmed they are actively planning to extend maturities and optimize their debt structure, maintaining leverage guidance between 30% and 35% LTV. They see positive indications from debt markets and are confident in delivering solid results. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Newsweek
9 minutes ago
- Newsweek
China's Xi Makes Trump Wait for Leader Talks
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The White House has been optimistic about the prospects for an in-person summit with Chinese President Xi Jinping—the first of President Donald Trump's second term. Yet analysts say the Chinese leader is likely holding out for concrete deliverables before agreeing to the high-profile meeting. All Eyes on Sweden Trump dramatically escalated the trade war with the world's second-largest economy in April, rolling out sweeping new tariffs that prompted China to respond with its own export duties and other measures. While Trump has said that "the confines of a deal" are in place ahead of a third round of talks between U.S. and Chinese negotiators, set for Sweden next week, several contentious issues remain unresolved. These include ongoing U.S. curbs on advanced chip exports to China and persistent geopolitical friction over influence in Asia and Beijing's threats toward Taiwan. Newsweek reached out to the White House and Chinese embassy in the U.S. via email for comment. Europe's Role Patrick Cronin, Asia-Pacific security chair at the Hudson Institute, told Newsweek: "A Xi-Trump summit is highly probable, but withholding final approval until Beijing can button down more information and as many concessions as possible is no doubt part of Xi's calculus." "What China and the United States can each negotiate with the EU will also help inform the China-US trade bargain that will be at the heart of any Xi-Trump summit," Cronin said. After months of efforts with dozens of countries, the White House recently secured a handful of deals with Japan, Vietnam, the Philippines and Indonesia, Cronin added. In a picture combination created on May 14, 2020, Chinese President Xi Jinping, left, and U.S. President Donald Trump are shown. In a picture combination created on May 14, 2020, Chinese President Xi Jinping, left, and U.S. President Donald Trump are shown. Dan Kitwood, Nicholas Kamm/AFP via Getty Images Among the deals Trump hopes to achieve is with the EU—a traditionally U.S.-aligned bloc that has become increasingly alienated by Trump's unpredictable trade moves and controversial domestic policies. Analysts say China has been seeking to exploit this rift and achieve a thaw in ties with Brussels that has deteriorated over issues like alleged Chinese market flooding with state-subsidized electric vehicles, human rights concerns and Beijing's support for Russia amid the war in Ukraine. Sean King, an Asia scholar and senior vice president at Park Strategies, told Newsweek: "PRC [People's Republic of China] leaders have long seen Europe as a comparatively easier mark, as the continent doesn't have America's Asian security concerns and obligations." He added, "It's probably better for Trump to first line up what he says are trade deals with friends and allies before going for the big one with Beijing." While European Commission President Ursula von der Leyen's visit to Beijing this week yielded a memorandum of understanding on climate change and an agreement to facilitate rare-earth exports, analysts note that a fundamental shift in EU-China ties remains elusive. Timetable Uncertain U.S. Secretary of State Marco Rubio, visiting Malaysia earlier this month for meetings with his Chinese counterpart Wang Yi, said that "the odds are high" a Trump-Xi summit will take place by the end of the year. Rosemary Foot, professor and senior research fellow at the University of Oxford's Department of Politics and International Relations, told Newsweek it's unlikely Xi is counting on Europe as leverage in his dealings with the White House. "I think that it is to do with China's more general approach to the Trump administration which is to wait for some intention to offer a serious deliverable from the meeting and perhaps also to paint President Trump as supplicant," she said. Trump and Xi last met in 2019 at the G20 summit in Osaka, Japan.
Yahoo
11 minutes ago
- Yahoo
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment
Zai Lab Ltd (NASDAQ:ZLAB) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On June 30, Leerink Partners raised its price target for the stock to $75 from $73. The research firm also reiterated an 'Outperform' rating on the stock. A doctor in a white coat discussing clinical trial results with a patient in an oncology practice. The research firm hiked its price target following positive Phase III trial results from the FORTITUDE-101 study. The study was evaluating bemarituzumab as a first-line FGFR2B-positive gastric cancer treatment. The candidate drug, developed in partnership with Amgen, met its primary endpoint while demonstrating a significant and clinically meaningful overall survival benefit compared to placebo plus chemotherapy. Following the positive results, Zai Labs plans a second Phase III trial, FORTITUDE-102, which will evaluate bemarituzumab in combination with chemotherapy and nivolumab. The company expects top-line data in the second half of the year that will affirm the candidate drug as a first-line treatment for gastric cancer. It also plans to file for regulatory approval in China following the positive results. Zai Lab Ltd (NASDAQ:ZLAB) is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders. While we acknowledge the potential of ZLAB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Goldman Sachs REIT Stocks: Top 12 Stock Picks. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
